Back
Arrowhead Pharmaceuticals Vs. IGC Pharma Industry Stock Comparison
Sell
39
ARWR
Arrowhead Pharmaceuticals
Last Price:
20.06
Seasonality Move:
80.06%
Sell
46
IGC
IGC Pharma
Last Price:
0.38
Seasonality Move:
-8.79%
Sell
39
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
- The current Arrowhead Pharmaceuticals [ARWR] share price is $20.06. The Score for ARWR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARWR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.38. The Score for IGC is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $20.06
The current trend is relatively stagnant and ARWR is experiencing slight buying pressure.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 50.48 | Buy |
| Chaikin Money Flow: | 223886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.54 - 20.38) | Buy |
| Bollinger Bands (100): | (20.04 - 26.7) | Sell |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 46.52 | Sell |
| Chaikin Money Flow: | -53403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.37 - 0.41) | Sell |
| Bollinger Bands (100): | (0.36 - 0.44) | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.84 | Buy |
| 20-day SMA: | 19.56 | Buy |
| 50-day SMA: | 20.64 | Sell |
| 200-day SMA: | 25.51 | Sell |
| 8-day EMA: | 19.81 | Buy |
| 20-day EMA: | 19.84 | Buy |
| 50-day EMA: | 20.81 | Sell |
| 200-day EMA: | 24.61 | Sell |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.39 | Sell |
| 20-day SMA: | 0.39 | Sell |
| 50-day SMA: | 0.37 | Buy |
| 200-day SMA: | 0.41 | Sell |
| 8-day EMA: | 0.39 | Sell |
| 20-day EMA: | 0.39 | Sell |
| 50-day EMA: | 0.39 | Sell |
| 200-day EMA: | 0.4 | Sell |
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Arrowhead Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||